*By Carlo Versano*
A new start-up wants to help patients and caregivers with the age-old problem of managing medications for chronic or serious illnesses.
Hero sprang from the mind of Kal Vepuri, whose aptly-named Brainchild Holdings led a $12 million investment round for the company, which produces an eponymous counter-top device that can store and dispense pills in pre-selected dosages at certain times.
Vepuri told Cheddar he came up with the idea after he became a caregiver for his ill mother.
"She took almost a dozen medications at one point," he said, and the task of organizing, remembering, and dispensing them, as well as dealing with multiple prescribing physicians and changing dosages became an overwhelming task.
So Vepuri took his experience as an entrepreneur and tech consultant to build Hero, which resembles a kitchen appliance married to an Apple device.
The problems surrounding medication management are what he called a "phantom issue" ー no one wants to talk about it, but a stunning number of people have to deal with it ー 70 million Americans have multiple chronic diseases, Vepuri said, and that number will unfortunately only go up as Baby Boomers age, and more millennials are tasked with taking care of their older parents (one-fourth of caregivers are already millennials).
"It's not really great dinner table conversation," he said, "But when you're one-on-one with somebody, and they bring up a problem that they've faced themselves and has been so personal to them and their family, they tend to understand it immediately."
The Hero device can't tell if a user has actually taken his or her pills, but it can remind that person (or a family member or caregiver) through an app notification.
Vepuri said he plans to use the new funding to educate consumers and develop partnerships and online direct-to-caregiver systems so that Hero can be a closed-loop solution for caregivers and patients alike.
For full interview [click here](https://cheddar.com/videos/healthcare-start-up-hero-launches-with-12-million-seed-funding).
AI is reshaping investigations. Longeye CEO Guillaume Delepine shares how their AI workspace empowers law enforcement to uncover insights faster and smarter.
Stephen Kates, Financial Analyst at Bankrate, joins to discuss the Fed’s 25-basis-point rate cut, inflation risks, and what it all means for consumers and marke
Big tech earnings take center stage as investors digest results from Alphabet, Meta, Microsoft, Amazon, and Apple, with insights from Gil Luria of D.A. Davidson
Disney content has gone dark on YouTube TV, leaving subscribers of the Google-owned live streaming platform without access to major networks like ESPN and ABC. That’s because the companies have failed to reach a new licensing deal to keep Disney channels on YouTube TV. Depending on how long it lasts, the dispute could particularly impact coverage of U.S. college football matchups over the weekend — on top of other news and entertainment disruptions that have already arrived. In the meantime, YouTube TV subscribers who want to watch Disney channels could have little choice other than turning to the company’s own platforms, which come with their own price tags.
President Donald Trump said he has decided to lower his combined tariff rates on imports of Chinese goods to 47% after talks with Chinese leader Xi Jinping on curbing fentanyl trafficking.
Universal Music Group and AI platform Udio have settled a copyright lawsuit and will collaborate on a new music creation and streaming platform. The companies announced on Wednesday that they reached a compensatory legal settlement and new licensing agreements. These agreements aim to provide more revenue opportunities for Universal's artists and songwriters. The rise of AI song generation tools like Udio has disrupted the music streaming industry, leading to accusations from record labels. This deal marks the first since Universal and others sued Udio and Suno last year. Financial terms of the settlement weren't disclosed.
